Author: Chen Dong; Ling Ni; Fang Ye; Meng-Li Chen; Yu Feng; Yong-Qiang Deng; Hui Zhao; Peng Wei; Jiwan Ge; Xiaoli Li; Lin Sun; Pengzhi Wang; Peng Liang; Han Guo; Xinquan Wang; Cheng-Feng Qin; Fang Chen
Title: Characterization of anti-viral immunity in recovered individuals infected by SARS-CoV-2 Document date: 2020_3_20
ID: dptgg05n_6
Snippet: Since RBD domain of the S protein has been shown to bind to human receptor ACE2 3 , the existence of antibodies against it may suggest neutralization of SARS-CoV-2 infection. To assess this, we performed pseudovirus particle-based neutralization assay. As shown in Figure 1B , patients #1, 2, 4 and 5, all within the discharged group, had high levels of neutralizing antibody titers. These results demonstrate that most recently discharged patients A.....
Document: Since RBD domain of the S protein has been shown to bind to human receptor ACE2 3 , the existence of antibodies against it may suggest neutralization of SARS-CoV-2 infection. To assess this, we performed pseudovirus particle-based neutralization assay. As shown in Figure 1B , patients #1, 2, 4 and 5, all within the discharged group, had high levels of neutralizing antibody titers. These results demonstrate that most recently discharged patients All rights reserved. No reuse allowed without permission. the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
Search related documents:
Co phrase search for related documents- antibody titer and discharge group: 1
- antibody titer and high level: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
- antibody titer and human receptor: 1
- antibody titer and neutralization assay: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- antibody titer and RBD domain: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- discharge group and high level: 1, 2, 3, 4
- high level and human receptor: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18
- high level and neutralization assay: 1, 2, 3, 4, 5, 6, 7, 8, 9
- high level and RBD domain: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- human receptor and neutralization assay: 1, 2, 3, 4, 5, 6, 7, 8
- human receptor and RBD domain: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- neutralization assay and RBD domain: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
Co phrase search for related documents, hyperlinks ordered by date